Testosterone replacement therapy and prostate cancer: A word of caution

被引：19
|
作者：
Brand T.C. [1 ]
Canby-Hagino E. [1 ]
Thompson I.M. [1 ]
机构：
[1] Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229
来源：
Current Urology Reports | 2007年 / 8卷 / 3期
关键词：
Prostate Cancer; Testosterone; Digital Rectal Examination; Free Testosterone; Prostatic Intraepithelial Neoplasia;
D O I：
10.1007/s11934-007-0004-x
中图分类号：
学科分类号：
摘要：
The number of men for whom testosterone is prescribed is rapidly Increasing. The aging man normally demonstrates a gradual decline in testosterone. Symptoms of hypogonadism include erectile dysfunction, diminished libido, sarcopenia, increased adiposity, osteopenia and osteoporosis, impaired cognition, and depression. There is a paucity of data regarding both efficacy and safety of testosterone replacement therapy. Testosterone levels have been shown to modulate prostate cancer risk and progression. A prospective evaluation of prostate cancer risk with testosterone replacement therapy has not been conducted. We outline concerns and recommendations for the use of testosterone replacement therapy in the aging man. Copyright © 2007 by Current Medicine Croup LLC.
引用
收藏
页码：185 / 189
页数：4
相关论文
共 50 条
  • [21] The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer
    Lopez, David S.
    Huang, Danmeng
    Tsilidis, Konstantinos K.
    Canfield, Steven
    Khera, Mohit
    Baillargeon, Jacques G.
    Kuo, Yong-Fang
    Peek, M. Kristen
    Platz, Elizabeth A.
    Markides, Kyriakos
    CANCER CAUSES & CONTROL, 2021, 32 (09) : 965 - 976
  • [22] Prostate cancer following testosterone replacement in Klinefelter syndrome
    Bydder, Sean A.
    Joseph, David J.
    Weinstein, Sydney
    Stuckey, Bronwyn G. A.
    ANZ JOURNAL OF SURGERY, 2007, 77 (1-2) : 93 - 94
  • [23] TESTOSTERONE THERAPY AND PROSTATE CANCER
    Suer, Ender
    Yaman, Onder
    TURKISH JOURNAL OF UROLOGY, 2008, 34 (01): : 27 - 30
  • [24] Testosterone therapy and prostate cancer
    Pastuszak, Alexander W.
    Rodriguez, Katherine M.
    Nguyen, Taylor M.
    Khera, Mohit
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2016, 5 (06) : 909 - 920
  • [25] The Role of Testosterone Therapy in the Setting of Prostate Cancer
    Katherine M. Rodriguez
    Alexander W. Pastuszak
    Mohit Khera
    Current Urology Reports, 2018, 19
  • [26] Testosterone Replacement Therapy in Men with Prostate Cancer: A Time-Varying Analysis
    Kaplan, Alan L.
    Lenis, Andrew T.
    Shah, Adit
    Rajfer, Jacob
    Hu, Jim C.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 (02) : 374 - 380
  • [27] Testosterone Replacement Therapy Following the Diagnosis of Prostate Cancer: Outcomes and Utilization Trends
    Kaplan, Alan L.
    Quoc-Dien Trinh
    Sun, Maxine
    Carter, Stacey C.
    Nguyen, Paul L.
    Shih, Ya-Chen Tina
    Marks, Leonard S.
    Hu, Jim C.
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 (04) : 1063 - 1070
  • [28] Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
    Kim, Jin Wook
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (03) : 242 - 249
  • [29] Prostate cancer after exogenous testosterone replacement therapy in a patient with pituitary insufficiency
    Halland, A
    Jonler, M
    Pedersen, KV
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2005, 39 (01): : 87 - 88
  • [30] The Role of Testosterone Therapy in the Setting of Prostate Cancer
    Rodriguez, Katherine M.
    Pastuszak, Alexander W.
    Khera, Mohit
    CURRENT UROLOGY REPORTS, 2018, 19 (08)
12345